Modern medicine is predicated on the safety provided by sterility assurance and aseptic practices. The United States Pharmacopeia defines these two important con...

A Turning Point for Drug Development Models The biopharmaceutical industry is at an inflexion point. For decades, animal models have served as the backbone of...

Drug developers face challenges in translating preclinical findings to safe and effective human trials. Traditionally,preclinical testing relies on a phased appr...

For decades, medicine has focused primarily on disease management. Patients with genetic disorders often required lifelong therapy, controlling symptoms but rare...

Messenger-RNA (mRNA) drug therapeutics have recently emerged as promising and increasingly viable treatment modalities for cancer, cardiovascular diseases, rare gene...

In the world of pharmaceutical and medical device manufacturing, there are various quality control tests that may be required for distinct product types from separat...

The success of GLP-1 receptor agonists as obesity therapeutics has initiated a seismic shift in the treatment paradigm and conceptual understanding of non-communicab...

Clinical trials bridge the gap between discovery and patient care, but high failure rates, unpredictable patient responses and data variability continue to challenge...

Autoimmune diseases such as lupus, type 1 diabetes, inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and rheumatoid arthritis are complex condition...

Peptide libraries have emerged as a transformative technology in drug discovery and development. These diverse collections of peptides, now mainly synthetic but also...